Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent To Increase Biologic Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Catalent To Increase Biologic Capabilities

New Wisconsin facility will quadruple capacity

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions plans to expand its biologics capabilities by relocating to a new, larger facility in Madison, WI, providing increased capacity for cell line and biomanufacturing solutions.
 
The new facility will quadruple capacity in Madison, allowing the company to enhance its offerings in the development and manufacturing of biologic products. The expansion will enhance Catalent’s GPEx cell line engineering technology and process development capabilities, as well as other mammalian cell lines. 
 
The new facility will include three individual cGMP compliant production suites that will increase Phase I and II production capacity to 1,000L bioreactors. Catalent will also transition from stainless steel bioreactors to single use bioreactors.

“Plans for the biologics facility are designed to meet our customers’ needs through improved delivery of integrated services in the areas of biologic development and manufacturing,” said Kent Payne, Ph.D., vice president and general manager of Catalent’s Biologics business. “This is the first step in a series of strategic development initiatives designed to enhance our offerings in this rapidly expanding market.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics